Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions
Open accessAbstract
Modern clinical research on psychedelics is generating interesting outcomes in a wide array of clinical conditions when psychedelic-assisted psychotherapy is delivered to appropriately screened participants and in controlled settings. Still, a number of patients relapse or are less responsive to such treatments. Individual and contextual factors (i.e., set and setting) seem to play a role in shaping the psychedelic experience and in determining clinical outcomes. These findings, coupled with data from literature on the effectiveness of psychotherapy, frame the therapeutic context as a potential moderator of clinical efficacy, highlighting the need to investigate how to functionally employ environmental and relational factors. In this review, we performed a structured search through two databases (i.e., PubMed/Medline and Scopus) to identify records of clinical studies on psychedelics which used and described a structured associated psychotherapeutic intervention. The aim is to construct a picture of what models of psychedelic-assisted psychotherapy are currently adopted in clinical research and to report on their clinical outcomes.Ad-hoc and adapted therapeutic methods were identified. Common principles, points of divergence and future directions are highlighted and discussed with special attention toward therapeutic stance, degree of directiveness and the potential suggestive effects of information provided to patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Contemporary clinical trials have invariably provided preparation and integration sessions before and after psilocybin administration, but the theoretical orientation and frequency of these sessions have varied across trials.
“Although contemporary clinical trials have invariably provided preparation and integration sessions before and after psilocybin administration, respectively, the theoretical orientation and frequency of these sessions have varied across trials (see [82] for a review).”
From Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial (2024) · cites this paper as [82]
The Discussion’s Preparation and Integration sections describe sessions around psychedelic administration, while the Results describe psilocybin approaches with different session schedules and therapeutic models (page numbers unavailable). But the review says preparation was “almost always” included and was explicitly mentioned in only 43 reviewed studies; it does not establish the claim that every contemporary psilocybin trial provided both kinds of session. (LLM, conf=0.84)
Experimental — accuracy not yet measuredPsychedelics enhance psychotherapeutic outcomes by facilitating cognitive, emotional, and behavioral transformations.
“Psychedelics have been shown to enhance psychotherapeutic outcomes by facilitating cognitive, emotional, and behavioral transformations (103, 106, 127).”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [106]
The Introduction says psychedelics may create an opportunity to modify rigid behaviors, thought patterns, and emotional reactions. The Discussion likewise proposes that enhanced learning and cognitive flexibility could improve psychotherapy. These passages support the proposed mechanism, but not the stronger claim that improved psychotherapeutic outcomes through those changes have been shown. (LLM, conf=0.87)
Experimental — accuracy not yet measuredDebate continues over which therapeutic modalities best complement psychedelic treatment, with various adapted and ad hoc models being evaluated in clinical research presently.
“Debate continues over which therapeutic modalities best complement psychedelic treatment (110–112), with various adapted and ad hoc models being evaluated in clinical research presently (106).”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., Hamilton, S., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05249-5 · Cited by 359 · see citing works
RetractedJerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05548-2 · Cited by 159 · see citing works
RetractedSelf-efficacy mechanism in human agency
Bandura, A. (1982) · American Psychologist · doi:10.1037/0003-066x.37.2.122 · Cited by 15,975 · see citing works
(1991) · Medical Entomology and Zoology · Cited by 4,438 · see citing works
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · see citing works
The Transtheoretical Approach: Crossing Traditional Boundaries of Therapy
Sporakowski, M. J., Prochaska, J. O., & DiClemente, C. C. (1986) · Family Relations · doi:10.2307/584540 · Cited by 1,982 · see citing works
A Multidimensional Meta-Analysis of Psychotherapy for PTSD
Bradley, R., Greene, J., Russ, E., Dutra, L., & Westen, D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.214 · Cited by 1,938 · see citing works
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · see citing works
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · see citing works
(1992) · PubMed · Cited by 1,429 · see citing works
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3285 · Cited by 1,301 · see citing works
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207 · see citing works
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · see citing works
Human hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203 · see citing works
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180 · see citing works
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · cited 19× · see citing works
“The first is the non-directive one (Grof and Halifax, 1978; Johnson et al., 2014; Bogenschutz et al., 2015; Carhart-Harris et al., 2016), in which therapists only aim at keeping the participants’ attention inward and provide verbal and non-verbal support during challenging moments.”
BackgroundMethodInfluentialFrank, J. (1993) · doi:10.56021/9780801840678 · Cited by 1,094 · see citing works
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G., M., Garas, W., Paleos, C., Gorman, I., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01336-3 · Cited by 1,004 · see citing works
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970 · see citing works
Pilot study of the 5-HT <sub>2A</sub> R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914 · cited 21× · see citing works
“The first is the non-directive one (Grof and Halifax, 1978; Johnson et al., 2014; Bogenschutz et al., 2015; Carhart-Harris et al., 2016), in which therapists only aim at keeping the participants’ attention inward and provide verbal and non-verbal support during challenging moments.”
BackgroundMethodInfluentialPalhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001356 · Cited by 852 · see citing works
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00974 · Cited by 808 · see citing works
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739 · see citing works
Long-term follow-up of psilocybin-facilitated smoking cessation
Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1170135 · Cited by 696 · see citing works
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378371 · Cited by 674 · see citing works
Psychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754710 · Cited by 657 · see citing works
Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., Kirkwood, K., aan het Rot, M., Lapidus, K. A. B., Wan, L.-B., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.62 · Cited by 613 · see citing works
Clinical Practice Guideline for Emergency Department Ketamine Dissociative Sedation: 2011 Update
Green, S. M., Roback, M. G., Kennedy, R. M., & KRAUSS, B. S. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.11.030 · Cited by 592 · see citing works
Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817709585 · Cited by 589 · see citing works
Posttraumatic stress disorder and intimate relationship problems: A meta-analysis.
Taft, C. T., Watkins, L. E., Stafford, J., Street, A. E., & Monson, C. M. (2011) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0022196 · Cited by 576 · see citing works
The Annual Meeting of the American Psychological Association
(1936) · Science · doi:10.1126/science.84.2174.197 · Cited by 573 · see citing works
Psilocybin-Occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu, A., Griffiths, R., & Johnson, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107121331 · Cited by 476 · see citing works
Constructing drug effects: a history of set and setting
Hartogsohn, I. (2017) · Drug Science Policy and Law · doi:10.1177/2050324516683325 · Cited by 472 · see citing works
Mithoefer, M. C., Mithoefer, A. T., Feduccia, A. A., Jerome, L., Wagner, M., Wymer, J., Holland, J., Hamilton, S., Yazar-Klosinski, B., Emerson, A., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30135-4 · Cited by 439 · see citing works
Mindfulness training for adolescents with externalizing disorders and their parents
Bögels, S., Hoogstad, B., van Dun, L., de Schutter, S., & Restifo, K. (2008) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465808004190 · Cited by 432 · see citing works
Oehen, P., Traber, R., Widmer, V., & Schnyder, U. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112464827 · Cited by 402 · see citing works
Preller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., Liechti, M. E., Seifritz, E., & Vollenweider, F. X. (2017) · Current Biology · doi:10.1016/j.cub.2016.12.030 · Cited by 402 · see citing works
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar‐Klosinski, B., Michel, Y., Brewerton, T. D., & Doblin, R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112456611 · Cited by 376 · see citing works
Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119897615 · Cited by 360 · see citing works
Andersen, K. A. A., Carhart‐Harris, R., Nutt, D. J., & Erritzoe, D. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13249 · Cited by 347 · see citing works
Blinding and expectancy confounds in psychedelic randomized controlled trials
Muthukumaraswamy, S. D., Forsyth, A., & Lumley, T. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1933434 · Cited by 324 · see citing works
Psychedelic Psychiatry’s Brave New World
Nutt, D., Erritzøe, D., & Carhart-Harris, R. L. (2020) · Cell · doi:10.1016/j.cell.2020.03.020 · Cited by 322 · see citing works
LSD enhances suggestibility in healthy volunteers
Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A., & Nutt, D. J. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3714-z · Cited by 320 · see citing works
Realms of the Human Unconscious: Observations from LSD Research
McLaughlin, S. C., & Grof, S. (1976) · Journal for the Scientific Study of Religion · doi:10.2307/1385643 · Cited by 311 · see citing works
Belser, A. B., Agin-Liebes, G., Swift, T. C., Terrana, S., Devenot, N., Friedman, H. L., Guss, J., Bossis, A., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817706884 · Cited by 311 · see citing works
Effect of Cognitive-Behavioral Couple Therapy for PTSD: A Randomized Controlled Trial
Monson, C. M., Fredman, S. J., Macdonald, A., Pukay-Martin, N. D., Resick, P. A., & Schnurr, P. P. (2012) · JAMA · doi:10.1001/jama.2012.9307 · Cited by 303 · see citing works
Psychedelic therapy for smoking cessation: qualitative analysis of participant accounts
Noorani, T., Garcia-Romeu, A., Swift, T. C., Griffiths, R. R., & Johnson, M. W. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118780612 · Cited by 285 · see citing works
Anderson, B. T., Danforth, A., Daroff, P. R., Stauffer, C., Ekman, E., Agin-Liebes, G., Trope, A., Boden, M. T., Dilley, P. J., Mitchell, J., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100538 · Cited by 284 · see citing works
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., Yazar-Klosinski, B., & Emerson, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5010-9 · Cited by 280 · cited 4× · see citing works
“Our search identified 1 RCT investigating the potential of MDMA-ATM in the treatment of social anxiety in adult autistic individuals (Danforth et al., 2018).”
BackgroundInfluentialMindfulness-based therapy in adults with an autism spectrum disorder: a randomized controlled trial
Spek, A. A., van Ham, N. C., & Nyklíček, I. (2013) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2012.08.009 · Cited by 274 · cited 1× · see citing works
“, 2016) and (d) evidence showing that practicing mindfulness skills has beneficial effects in social, emotional and cognitive areas of functioning of autistic individuals (Bögels et al., 2008; Spek et al., 2013).”
BackgroundThe hidden therapist: evidence for a central role of music in psychedelic therapy
Kaelen, M., Giribaldi, B., Raine, J., Evans, L., Timmermann, C., Rodriguez, N., Roseman, L., Feilding, A., Nutt, D., & Carhart-Harris, R. L. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4820-5 · Cited by 271 · see citing works
de Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269 · see citing works
Self-citationLambert, J. E., Engh, R., Hasbun, A., & Holzer, J. (2012) · Journal of Family Psychology · doi:10.1037/a0029341 · Cited by 268 · see citing works
Effects of psilocybin therapy on personality structure
Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart‐Harris, R. L. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12904 · Cited by 267 · see citing works
Majić, T., Schmidt, T. T., & Gallinat, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114568040 · Cited by 260 · see citing works
Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research
Krupitsky, E. M., & Grinenko, A. Y. (1997) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1997.10400185 · Cited by 246 · see citing works
Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up
Krupitsky, E., Burakov, A., Romanova, T., Dunaevsky, I., Strassman, R., & Grinenko, A. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00275-1 · Cited by 246 · see citing works
Marcela Ot’alora, G., Grigsby, J., Poulter, B., Derveer, J. W. V., Giron, S. G., Jerome, L., Feduccia, A. A., Hamilton, S., Yazar‐Klosinski, B., Emerson, A., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118806297 · Cited by 233 · see citing works
The experimental use of psychedelic (LSD) psychotherapy.
Pahnke, W. N. (1970) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1970.03170240060010 · Cited by 220 · see citing works
McCallie, M. S., Blum, C. M., & Hood, C. J. (2006) · Journal of Human Behavior in the Social Environment · doi:10.1300/j137v13n03_04 · Cited by 211 · see citing works
LSD-Assisted Psychotherapy in Patients with Terminal Cancer
Grof, S., Goodman, L. E., Richards, W. A., & Kurland, A. A. (2017) · International Pharmacopsychiatry · doi:10.1159/000467984 · Cited by 209 · see citing works
Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119895520 · Cited by 208 · see citing works
Bouso, J. C., Doblin, R., Farré, M., Alcázar‐Córcoles, M. Á., & Gómez-Jarabo, G. (2008) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2008.10400637 · Cited by 205 · see citing works
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
Kuypers, K. P. C., Riba, J., de la Fuente Revenga, M., Barker, S., Theunissen, E. L., & Ramaekers, J. G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4377-8 · Cited by 201 · see citing works
Self-citationSwift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N., Terrana, S., Friedman, H. L., Guss, J., Bossis, A. P., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817715966 · Cited by 195 · see citing works
Single Versus Repeated Sessions of Ketamine-Assisted Psychotherapy for People with Heroin Dependence
Krupitsky, E. M., Burakov, A. M., Dunaevsky, I. V., Romanova, T. N., Slavina, T. Y., & Grinenko, A. Y. (2007) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2007.10399860 · Cited by 183 · see citing works
Dakwar, E., Levin, F., Hart, C. L., Basaraba, C., Choi, J., Pavlicova, M., & Nunes, E. V. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19070684 · Cited by 183 · see citing works
A Method of Conducting Therapeutic Sessions with MDMA
Greer, G. R., & Tolbert, R. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399713 · Cited by 182 · see citing works
Antidepressants for the treatment of depression in people with cancer
Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. H. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub2 · Cited by 178 · see citing works
Pharmacological Treatments for Smoking Cessation
Cahill, K., Stevens, S., & Lancaster, T. (2014) · JAMA · doi:10.1001/jama.2013.283787 · Cited by 177 · see citing works
Wolfson, P. E., Andries, J., Feduccia, A. A., Jerome, L., Wang, J. B., Williams, E., Carlin, S. C., Sola, E., Hamilton, S., Yazar-Klosinski, B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75706-1 · Cited by 169 · see citing works
Antidepressants for the treatment of depression in people with cancer
Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub3 · Cited by 158 · see citing works
(1969) · PubMed · Cited by 150 · see citing works
Richards, W. A. (2015) · Columbia University Press eBooks · doi:10.7312/columbia/9780231174060.001.0001 · Cited by 149 · see citing works
Sessa, B., Higbed, L., O’Brien, S., Durant, C. F., Sakal, C., Titheradge, D., Williams, T. M., Rose‐Morris, A., Brew-Girard, E., Burrows, S., et al. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881121991792 · Cited by 136 · see citing works
The Use of LSD in Psychotherapy and Alcoholism
Blaine, G. B. (1968) · Psychosomatic Medicine · doi:10.1097/00006842-196807000-00014 · Cited by 135 · see citing works
Posttraumatic stress disorder in an interpersonal context.
Monson, C. M., Fredman, S. J., & Dekel, R. (2010) · American Psychological Association eBooks · doi:10.1037/12084-007 · Cited by 132 · see citing works
Individual experiences in four cancer patients following psilocybin-assisted psychotherapy
Malone, T. C., Mennenga, S. E., Guss, J., Podrebarac, S. K., Owens, L. T., Bossis, A. P., Belser, A. B., Agin-Liebes, G., Bogenschutz, M. P., & Ross, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00256 · Cited by 131 · cited 9× · see citing works
“Our search identified 2 papers investigating the efficacy of TIMBER on a single sample in the context of a RCT (Pradhan et al., 2017, 2018).”
BackgroundInfluentialLow doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers
Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., Theunissen, E. L., Holze, F., Liechti, M. E., Varghese, N., Eckert, A., Feilding, A., Ramaekers, J. G., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00099 · Cited by 131 · see citing works
Self-citationBogenschutz, M. P., Podrebarac, S. K., Duane, J. H., Amegadzie, S. S., Malone, T. C., Owens, L. T., Ross, S., & Mennenga, S. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00100 · Cited by 128 · see citing works
Wilkinson, S. T., Wright, D., Fasula, M. K., Fenton, L. R., Griepp, M., Ostroff, R. B., & Sanacora, G. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000457960 · Cited by 122 · see citing works
Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine
Johnson, M. W. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00198 · Cited by 114 · see citing works
Nielson, E. M., May, D. G., Forcehimes, A. A., & Bogenschutz, M. P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00132 · Cited by 113 · see citing works
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults
Danforth, A. L., Struble, C. M., Yazar‐Klosinski, B., & Grob, C. S. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.011 · Cited by 110 · see citing works
Wilkinson, S. T., Rhee, T. G., Joormann, J., Webler, R., Ortiz Lopez, M., Kitay, B., Fasula, M., Elder, C., Fenton, L., & Sanacora, G. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000517074 · Cited by 108 · see citing works
Stroud, J., Freeman, T. P., Leech, R., Hindocha, C., Lawn, W., Nutt, D., Curran, H. V., & Carhart-Harris, R. L. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4754-y · Cited by 104 · see citing works
Rothberg, R. L., Azhari, N., Haug, N. A., & Dakwar, E. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120970879 · Cited by 97 · see citing works
Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide
Kast, E. (1967) · The Psychiatric Quarterly · doi:10.1007/bf01575629 · Cited by 94 · see citing works
A New Adjunct to the Treatment of Alcoholism: The Hallucinogenic Drugs
Smith, C. M. (1958) · Quarterly Journal of Studies on Alcohol · doi:10.15288/qjsa.1958.19.406 · Cited by 94 · see citing works
Monson, C. M., Wagner, A. C., Mithoefer, A. T., Liebman, R. E., Feduccia, A. A., Jerome, L., Yazar-Klosinski, B., Emerson, A., Doblin, R., & Mithoefer, M. C. (2020) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1840123 · Cited by 91 · cited 6× · see citing works
“, 2014) and in the CBCT plus MDMA (Monson et al., 2020), no explicit mention of interventions to improve therapeutic alliance was made.”
BackgroundMethodInfluentialBahji, A., Forsyth, A., Groll, D., & Hawken, E. R. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109735 · Cited by 88 · see citing works
Wheeler, S. W., & Dyer, N. L. (2020) · Psychology of Consciousness: Theory, Research, and Practice · doi:10.1037/cns0000237 · Cited by 74 · see citing works
Berlowitz, I., Walt, H., Ghasarian, C., Mendive, F., & Martin-Soelch, C. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1607956 · Cited by 72 · see citing works
LYSERGIC ACID DIETHYLAMIDE AS A VARIABLE IN THE HOSPITAL TREATMENT OF ALCOHOLISM
Bowen, W. T., Soskin, R. A., & Chotlos, J. W. (1970) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197002000-00003 · Cited by 70 · see citing works
Stauffer, C. S., Anderson, B. T., Ortigo, K. M., & Woolley, J. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00169 · Cited by 65 · cited 3× · see citing works
“Results showed clinically relevant change in demoralization (Anderson et al., 2020) and significant reductions in self-reported attachment anxiety at the 3-month follow-up (Stauffer et al., 2021).”
BackgroundPradhan, B., Mitrev, L. V., Moaddel, R., & Wainer, I. W. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.03.006 · Cited by 63 · see citing works
Effectiveness of a cognitive behaviour therapy self-help programme for smokers in London, UK
Sykes, C. M. (2001) · Health Promotion International · doi:10.1093/heapro/16.3.255 · Cited by 62 · see citing works
Barone, W., Beck, J., Mitsunaga-Whitten, M., & Perl, P. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1580805 · Cited by 61 · see citing works
LSD in the Supportive Care of the Terminally Ill Cancer Patient
Kurland, A. A. (1985) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1985.10524332 · Cited by 58 · see citing works
Giovannetti, C., Garcia Arce, S., Rush, B., & Mendive, F. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1789247 · Cited by 56 · see citing works
Sessa, B., Sakal, C., O’Brien, S., & Nutt, D. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-230109 · Cited by 55 · see citing works
Jardim, A. V., Jardim, D. V., Chaves, B. R., Steglich, M. S., Marcela Ot’alora, G., Mithoefer, M. C., da Silveira, D. X., Tófoli, L. F., Ribeiro, S. T. G., Matthews, R., et al. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0980 · Cited by 54 · see citing works
Agin-Liebes, G., Ekman, E., Anderson, B., Malloy, M., Haas, A., & Woolley, J. (2024) · Journal of Humanistic Psychology · doi:10.1177/00221678211022949 · Cited by 51 · see citing works
The Combination of Psychedelic and Aversive Approaches in Alcoholism Treatment
Krupitsky, E. M., Grineko, A. Y., Беркалиев, Т. Н., Paley, A. I., Tetrov, U. N., Mushkov, K. A., & Borodikin, Y. S. (1992) · Alcoholism Treatment Quarterly · doi:10.1300/j020v09n01_09 · Cited by 49 · see citing works
Pradhan, B., Wainer, I. W., Moaddel, R., Torjman, M. C., Goldberg, M., Sabia, M., Parikh, T., & Pumariega, A. (2017) · Asia Pacific Journal of Clinical Trials Nervous System Diseases · doi:10.4103/2542-3932.211589 · Cited by 49 · see citing works
Liebman, R. E., Whitfield, K. M., Sijercic, I., Ennis, N., & Monson, C. M. (2020) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-020-00211-1 · Cited by 47 · see citing works
Kolp, E., Young, M. S., Florida Mental Health Institute of University of South Florida, Friedman, H., University of Florida, Krupitsky, E., St. Petersburg State Pavlov Medical University, Jansen, K., O’Connor, L.-A., & Argosy University (2007) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2007.26.1.1 · Cited by 45 · see citing works
Effects of Cognitive–Behavioral Conjoint Therapy for PTSD on Partners’ Psychological Functioning
Shnaider, P., Pukay‐Martin, N. D., Fredman, S. J., Macdonald, A., & Monson, C. M. (2014) · Journal of Traumatic Stress · doi:10.1002/jts.21893 · Cited by 41 · see citing works
A randomized trial of short psychotherapy versus sustained‐release bupropion for smoking cessation
Zernig, G., Wallner, R., Grohs, U., Kriechbaum, N., Kemmler, G., & Saria, A. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02348.x · Cited by 40 · see citing works
Kolp, E., Friedman, H. L., Young, M. S., & Krupitsky, E. M. (2006) · The Humanistic Psychologist · doi:10.1207/s15473333thp3404_7 · Cited by 39 · see citing works
Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD
Wagner, A. C., Liebman, R. E., Mithoefer, A. T., Mithoefer, M. C., & Monson, C. M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.702838 · Cited by 38 · see citing works
Catalysts for change: the cellular neurobiology of psychedelics
Banks, M. I., Zahid, Z., Jones, N., Sultan, Z. W., & Wenthur, C. J. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-05-0340 · Cited by 37 · see citing works
Cognitive-behavioral treatment of borderline personality disorder
Tait, A. (1997) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(96)00357-1 · Cited by 35 · see citing works
Müller, F., Mühlhauser, M., Holze, F., Lang, U. E., Walter, M., Liechti, M. E., & Borgwardt, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.573953 · Cited by 31 · see citing works
Phantom Limb Pain: Sub‐Hallucinogenic Treatment With Lysergic Acid Diethylamide (LSD‐25)
Fanciullacci, M., Bene, E. D., Franchi, G., & Sicuteri, F. (1977) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1977.hed1703118.x · Cited by 30 · see citing works
Marks, D. F., & Sykes, C. M. (2002) · Psychology Health & Medicine · doi:10.1080/13548500120101513 · Cited by 28 · see citing works
Wagner, A., Mithoefer, M., Mithoefer, A., & Monson, C. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1589028 · Cited by 27 · see citing works
Ocker, A., Shah, N. B., Schwenk, E. S., Witkowski, T. A., Cohen, M. J. M., & Viscusi, E. R. (2019) · Pain Practice · doi:10.1111/papr.12829 · Cited by 23 · see citing works
Critical Conditions for Change in the Addictive Behaviors
Orford, J. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2191-0_5 · Cited by 20 · see citing works
Blinding and expectancy confounds in psychedelic randomised controlled trials
Muthukumaraswamy, S., Forsyth, A., & Lumley, T. (2021) · doi:10.31234/osf.io/q2hzm · Cited by 15 · see citing works
Pradhan, B., & Pinninti, N. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-30521-9_5 · Cited by 5 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Abramson H. A. (1960). The use of LSD in psychotherapy, in Transactions of a conference on d-lysergic acid diethylamide, LSD-25 eds Abramson H. A (Princeton, NJ)
- Institute of Medicine (2014). Treatment for Posttraumatic Stress Disorder in Military and Veteran Populations: Final Assessment. Washington, DC: The National Academies Press. 25077185
- Prochaska J. DiClemente C. (1985). Processes and stages of change in smoking, weight control, and psychological distress. Coping Subst. Abuse (Academic Press), 319– 345.
Cited by
Sorted by citations
Palitsky, R., Kaplan, D. M., Peacock, C., Zarrabi, A. J., Maples‐Keller, J. L., Grant, G. H., Dunlop, B. W., & Raison, C. L. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.1554 · Cited by 91 · see citing works
Therapeutic mechanisms of psychedelics and entactogens
Heifets, B. D., & Olson, D. E. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01666-5 · Cited by 67 · see citing works
Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’
McAlpine, R. G., Blackburne, G., & Kamboj, S. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-53829-z · Cited by 51 · see citing works
Compassion as a Skill: A Comparison of Contemplative and Evolution-Based Approaches
Gilbert, P., & Gordon, W. V. (2023) · Mindfulness · doi:10.1007/s12671-023-02173-w · Cited by 56 · see citing works
Psychedelic-assisted psychotherapy: Where is the psychotherapy research
Aday, J. S., Horton, D., Fernandes-Osterhold, G., O’Donovan, A., Bradley, E. R., Rosen, R. C., & Woolley, J. D. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06620-x · Cited by 54 · see citing works
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Mastinu, A., Anyanwu, M., Carone, M., Abate, G., Bonini, S. A., Peron, G., Tirelli, E., Pucci, M., Ribaudo, G., Oselladore, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021329 · Cited by 49 · see citing works
The need for establishing best practices and gold standards in psychedelic medicine
Feduccia, A. A., Agin-Liebes, G., Price, C. M., Grinsell, N., Paradise, S., & Rabin, D. M. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.03.083 · Cited by 43 · see citing works
Schipper, S., Nigam, K. B., Schmid, Y., Piechotta, V., Ljuslin, M., Beaussant, Y., Schwarzer, G., & Boehlke, C. S. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015383.pub2 · Cited by 44 · see citing works
Luquiens, A., Belahda, D., Graux, C., Igounenc, N., Serrand, C., Rochefort, P., Mura, T., & Sergent, F. (2025) · Addiction · doi:10.1111/add.70152 · Cited by 37 · see citing works
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression
Ramaekers, J. G., Reckweg, J. T., & Mason, N. L. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230890 · Cited by 32 · see citing works
Self-citationMcIntyre, R. S., Kwan, A. T. H., Mansur, R. B., Oliveira-Maia, A. J., Teopiz, K. M., Maletic, V., Suppes, T. M., Stahl, S. M., & Rosenblat, J. D. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230902 · Cited by 32 · see citing works
Zamaria, J. A., Fernandes-Osterhold, G., Shedler, J., & Yehuda, R. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1505894 · Cited by 29 · see citing works
Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study
Cavarra, M., Mason, N. L., Kuypers, K. P. C., Bonnelle, V., Smith, W., Feilding, A., Kryskow, P., & Ramaekers, J. G. (2023) · European Journal of Pain · doi:10.1002/ejp.2171 · Cited by 29 · see citing works
Self-citationStrategies for resolving challenging psychedelic experiences: insights from a mixed-methods study
Wood, M. J., McAlpine, R. G., & Kamboj, S. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-79931-w · Cited by 29 · see citing works
Peacock, C., Mascaro, J. S., Brauer, E., Zarrabi, A. J., Dunlop, B. W., Maples‐Keller, J. L., Grant, G. H., Raison, C. L., Rab, F., & Palitsky, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296071 · Cited by 27 · see citing works
Psychedelic treatments for mental health conditions pose challenges for informed consent
Seybert, C., Cotovio, G., Madeira, L., Ricou, M., Pires, A. M., & Oliveira-Maia, A. J. (2023) · Nature Medicine · doi:10.1038/s41591-023-02378-5 · Cited by 27 · see citing works
Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review
Chisamore, N., Johnson, D. E., Chen, M. J. Q., Offman, H., Chen-Li, D. C. J., Kaczmarek, E. S., Doyle, Z., McIntyre, R. S., & Rosenblat, J. D. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.05.051 · Cited by 26 · see citing works
A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials
Kishon, R., Modlin, N. L., Cycowicz, Y. M., Mourtada, H., Wilson, T., Williamson, V., Cleare, A. J., & Rucker, J. (2024) · npj Mental Health Research · doi:10.1038/s44184-024-00068-9 · Cited by 27 · see citing works
Larrea, A., Sánchez-Sánchez, L., Díez-Martín, E., Elexpe, A., Torrecilla, M., Astigarraga, E., & Barreda‐Gómez, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061727 · Cited by 28 · see citing works
O’Donnell, K. C., Alpert, M., Okano, L., Nicholas, C. R. N., Thomas, C., Poulter, B., Mithoefer, A. T., Mithoefer, M. C., & Marcela Ot’alora, G. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1427531 · Cited by 25 · see citing works
Pressing regulatory challenges for psychedelic medicine
McGuire, A. L., Lynch, H. F., Grossman, L. A., & Cohen, I. G. (2023) · Science · doi:10.1126/science.adg1324 · Cited by 19 · see citing works
Lucido, M. J., & Dunlop, B. W. (2025) · Brain Sciences · doi:10.3390/brainsci15020161 · Cited by 19 · see citing works
Psychedelics and Evidence-based Psychotherapy
Leone, L., McSpadden, B., DeMarco, A., Enten, L., Kline, R., & Fonzo, G. A. (2024) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2024.02.006 · Cited by 18 · see citing works
Development of a digital intervention for psychedelic preparation (DIPP)
McAlpine, R. G., Sacchet, M. D., Simonsson, O., Khan, M. M., Krajnović, K., Morometescu, L., & Kamboj, S. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-54642-4 · Cited by 17 · see citing works
Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review
Estric, C., Duron, T., Kabani, S., & López‐Castromán, J. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251338214 · Cited by 17 · see citing works
Kittur, M. E., M, L. A. B., Jones, B. D. M., Blumberger, D. M., Mulsant, B. H., Rosenblat, J. D., & Husain, M. I. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119952 · Cited by 18 · see citing works
Kamilar-Britt, P., Gordis, E. B., & Earleywine, M. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2023.0020 · Cited by 17 · see citing works
Psilocybin as a novel treatment for chronic pain
Askey, T., Lasrado, R., Maiarù, M., & Stephens, G. J. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17420 · Cited by 17 · see citing works
Hultgren, J., Hafsteinsson, M. H., & Brulin, J. G. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.07.020 · Cited by 16 · see citing works
A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia
Hatfield, S. P., Thornton, N. L. R., Greenstien, K., & Glozier, N. (2024) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674241240597 · Cited by 14 · see citing works
Daldegan‐Bueno, D., Donegan, C. J., Forsyth, A., Sumner, R. L., Murphy, R. J., Menkes, D. B., Evans, W., Hoeh, N. R., Sundram, F., Reynolds, L., et al. (2024) · Trials · doi:10.1186/s13063-024-08384-3 · Cited by 14 · see citing works
LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics
Shinozuka, K., Tewarie, P. K. B., Luppi, A. I., Lynn, C. W., Roseman, L., Muthukumaraswamy, S. D., Nutt, D. J., Carhart-Harris, R. L., Deco, G., & Kringelbach, M. L. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00420 · Cited by 16 · see citing works
Vanderijst, L., Hever, F., Buot, A., Dauré, C., Benoit, J., Hanak, C., Veeser, J., Morgiève, M., Campanella, S., Kornreich, C., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05502-y · Cited by 13 · see citing works
“Although contemporary clinical trials have invariably provided preparation and integration sessions before and after psilocybin administration, respectively, the theoretical orientation and frequency of these sessions have varied across trials (see [82] for a review).”
BackgroundKey competencies for psychedelic treatment in real-world mental health care settings
Wolff, M., Rutrecht, H. M., Gründer, G., Jungaberle, A., & Jungaberle, H. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.09.003 · Cited by 14 · see citing works
Pouyan, N., Sisi, F. Y., Kargar, A., Scheidegger, M., McIntyre, R. S., & Morrow, J. D. (2023) · CNS Drugs · doi:10.1007/s40263-023-01044-1 · Cited by 13 · see citing works
History, Hype, and Responsible Psychedelic Medicine: A Qualitative Study of Psychedelic Researchers
Barber, M., Gardner, J., & Carter, A. (2024) · Journal of Bioethical Inquiry · doi:10.1007/s11673-024-10386-4 · Cited by 13 · see citing works
Psychedelics and the treatment of eating disorders: considerations for future research and practice
Lacroix, E., Fatur, K., Hay, P., Touyz, S. W., & Keshen, A. R. (2024) · Journal of Eating Disorders · doi:10.1186/s40337-024-01125-6 · Cited by 13 · see citing works
Spending Time in Nature: The Overlooked Health Behavior
Maddock, J. E., & Johnson, S. S. (2023) · American Journal of Health Promotion · doi:10.1177/08901171231210806 · Cited by 14 · see citing works
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects
McCulloch, D. E.-W., Liechti, M. E., Kuypers, K. P. C., Nutt, D., Lundberg, J., Stenbæk, D. S., Goodwin, G. M., Gründer, G., Butlen‐Ducuing, F., Haberkamp, M., et al. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.103938 · Cited by 12 · see citing works
Self-citationPsychedelics as a potential treatment for tobacco use disorder: a systematic review
Spoelstra, S. K., Schoevers, R. A., Venema, S. D., & Knegtering, H. (2024) · Discover Mental Health · doi:10.1007/s44192-024-00095-0 · Cited by 12 · see citing works
Sarasso, P., Tschacher, W., Schoeller, F., Francesetti, G., Roubal, J., Gecele, M., Sacco, K., & Ronga, I. (2024) · Physics of Life Reviews · doi:10.1016/j.plrev.2024.09.005 · Cited by 12 · see citing works
Current perspectives on psychedelic treatments in Europe
Madero, S., Soto-Angona, Ó., Oña, G., Sánchez‐Moreno, J., & Vieta, E. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2025.101537 · Cited by 10 · see citing works
Glynos, N. G., Baker, A., Aday, J. S., Pouyan, N., Barron, J., Herberholz, M., Kruger, D. J., & Boehnke, K. F. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2405685 · Cited by 10 · see citing works
Weleff, J., Nunes, J. C., Costa, G. P. A., Sofuoglu, M., MacLean, R. R., & Aquino, J. P. D. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16045 · Cited by 11 · see citing works
Efthimiou, A. A., Cardinale, A. M., & Kepa, A. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2023.0058 · Cited by 10 · see citing works
Casu, M., Farrauto, C., Farruggio, G., Bellissima, S., Battiato, S., & Caponnetto, P. (2024) · Psychology International · doi:10.3390/psycholint6020036 · Cited by 8 · see citing works
Rougemont-Bücking, A., Guenot, F., Salamin, V., Gothuey, I., Duffour, C., King-Olivier, J., Girard, V., & Naudin, J. (2024) · European Journal of Trauma & Dissociation · doi:10.1016/j.ejtd.2024.100431 · Cited by 8 · see citing works
Adams, D. R., ALLEN, H. L., Nicol, G. E., & Cabassa, L. J. (2024) · Translational Behavioral Medicine · doi:10.1093/tbm/ibae053 · Cited by 10 · see citing works
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper
Destoop, M., Mohr, P., Butlen‐Ducuing, F., Kéri, P., Samochowiec, J., Picker, L. D., Fiorillo, A., Kuypers, K. P. C., & Dom, G. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2024.1806 · Cited by 8 · see citing works
Self-citationCan we effectively manage binge eating disorder with pharmacotherapy?
Hay, P., de Moraes, C. E. F., & Appolinário, J. C. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2428371 · Cited by 8 · see citing works
Earleywine, M., Oliva, A. B., Leo, J. A. D., & Banks, R. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00265 · Cited by 8 · see citing works
Kruger, D. J., Argyri, E. K., Mogilski, J. K., Herberholz, M., Barron, J., Aday, J. S., & Boehnke, K. F. (2025) · The Journal of Sex Research · doi:10.1080/00224499.2025.2479197 · Cited by 7 · see citing works
Can research on entactogens contribute to a deeper understanding of human sexuality?
Holka-Pokorska, J. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00552-7 · Cited by 7 · see citing works
Albert, A. E., & Back, A. L. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1529427 · Cited by 6 · see citing works
“Conversely, proponents of a synergistic approach contend that psychedelics enhance therapeutic outcomes when combined with psychotherapy (106 – 109).”
A primer for culturally attuned psychedelic clinical trials
Ching, T. H. W., & Kelmendi, B. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00394 · Cited by 6 · see citing works
Dwyer, J., Johnston, R. B., O'Callaghan, C., Kallianis, V., & Ross, M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1541528 · Cited by 6 · see citing works
Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review
Veraart, J. K. E., Schimmers, N., Breeksema, J. J., Seybert, C., Kamphuis, J., Huber, L. F. T., Rota, A., Coerts, D. T., Oliveira-Maia, A. J., & Schoevers, R. A. (2026) · Clinical Psychology Review · doi:10.1016/j.cpr.2026.102706 · Cited by 7 · see citing works
Jones, J. L. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1565852 · Cited by 6 · see citing works
What are set and setting: Reducing vagueness to improve research and clinical practice
Patch, K., & Smith, W. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251337372 · Cited by 5 · see citing works
Maples‐Keller, J. L., & ROTHBAUM, B. O. (2025) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2025.02.001 · Cited by 4 · see citing works
Harm reduction practises for users of psychedelic drugs: a scoping review
Dutton, C., North, E., Tie, Y. C., Oliva, J., & Skeffington, P. (2025) · Harm Reduction Journal · doi:10.1186/s12954-025-01264-2 · Cited by 4 · see citing works
Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder
Gold, N. D., Pagni, B. A., Petridis, P. D., & Bogenschutz, M. P. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2024.0030 · Cited by 4 · see citing works
Music and non-music approaches in psilocybin-assisted psychotherapy: The sound of silence
Gloeckler, S. G., Lévesque, J. T., Lehmann, A., Farzin, H., & Greenway, K. T. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00421 · Cited by 4 · see citing works
Henry, J. S., Giribaldi, B., Nutt, D. J., Erritzøe, D., Carhart-Harris, R. L., & Lyons, T. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.06.003 · Cited by 4 · see citing works
Walker, C., Piatkowski, T. M., Ferris, J., Davies, E., Barratt, M. J., WINSTOCK, A. R., & Puljević, C. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241265762 · Cited by 5 · see citing works
Psychedelics and Mental Health Treatment Seeking Among Asians and Hawaiians
Viña, S. M. (2025) · Psychoactives · doi:10.3390/psychoactives4030032 · Cited by 3 · see citing works
Mertens, L. J., Betzler, F., Brand, M., Evens, R., Jungaberle, A., Jungaberle, H., Kärtner, L., Majić, T., Schmitz, C. N., Ströhle, A., et al. (2026) · Psychotherapy and Psychosomatics · doi:10.1159/000552272 · Cited by 3 · see citing works
A landscape analysis of psychedelic facilitation training in the US
Palitsky, R., Peacock, C., Breau, J. A., Gillis-Smith, P., & Sklodowska, G. (2026) · PLoS ONE · doi:10.1371/journal.pone.0350037 · Cited by 2 · see citing works
Hughes, S., Terpak, L., Capps, R., Peters, P., Lilly, N., & Rivard, D. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00375 · Cited by 3 · see citing works
Petrovitch, D., Victor, S. E., Schmidt, A. T., Schmitz, J. M., Meyer, T. D., Stotts, A. L., & Littlefield, A. K. (2025) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-025-00371-y · Cited by 3 · see citing works
The Therapeutic Potential of Psychedelics on Reducing Rumination: A Mini-Review
Ramarushton, B., Blumenthal, H., Ryals, A. J., Boals, A., & Thompson, L. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2024.0009 · Cited by 2 · see citing works
With great power comes great responsibility: Promise and caution in the new psychedelic renaissance
Halma, M. T. J., Levy, R., & Varón, J. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100286 · Cited by 2 · see citing works
Meaning and Psychedelics in Palliative Care: A Narrative Review
Alexander, W. B., Hansen, E., Anderson, B. T., Zarrabi, A. J., Rogers, A. H., Loewen, G., Ficcaro, Z. R., Alexander, M. H., Schaefer, D., & Case, A. A. (2025) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2025.10.015 · Cited by 2 · see citing works
Anchesi, I., Astorino, M. F., Raffaele, I., Donato, D. S., Silvestro, S., Minuti, A., Calabrò, M., Scuruchi, M., & Cipriano, G. L. (2025) · Cells · doi:10.3390/cells14231872 · Cited by 2 · see citing works
Matos, R. S., Silva, A. C., Rego, L., Fernandes, R., & Gonçalves, S. D. (2025) · Palliative Medicine · doi:10.1177/02692163251383335 · Cited by 2 · see citing works
Świeczkowski, D., Kwaśny, A., Sadko, K. G., & Cubała, W. J. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.112746 · Cited by 2 · see citing works
Varela, Y. M., Tavares, V. D. D. O., Delgado, L. M., de Faria, H. A. T., Menezes, L. Q., Almeida, R. M., Agrícola, P. M. D., de Carvalho, B. S., Bienemann, B., Falchi-Carvalho, M., et al. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02188-5 · Cited by 2 · see citing works
Szpak, V., Kim, A., Sager, Z. S., & Suzuki, J. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00517-y · Cited by 2 · see citing works
Synthesizing Attachment Theory with the REBUS Model
Cherniak, A. D., Carhart-Harris, R. L., Brulin, J. G., Mikulincer, M., Östlind, S., & Granqvist, P. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780192844064.013.17 · Cited by 2 · see citing works
O'Connor, S., Godfrey, K., Reed, S., Peill, J. M., Rohani-Shukla, C., Healy, M., Robbins, T. W., de Souza, A. M. F. L. P., Tyacke, R. J., Papasyrou, M., et al. (2025) · Cureus · doi:10.7759/cureus.78171 · Cited by 2 · see citing works
Is there a place for psychedelics in sports practice?
Portes, M. A. M., Werle, I., & Bertoglio, L. J. (2025) · Acta Neuropsychiatrica · doi:10.1017/neu.2025.13 · Cited by 2 · see citing works
Enhanced independence: De-biasing processes in psychedelic research and beyond
Cheung, K., Ehrenkranz, R. C., & Yaden, D. B. (2025) · Research Ethics · doi:10.1177/17470161251326588 · Cited by 2 · see citing works
Leonard, D., & Brooks, T. R. (2025) · Journal of Humanistic Psychology · doi:10.1177/00221678251330066 · Cited by 2 · see citing works
Fradet, M. (2025) · Psychoactives · doi:10.3390/psychoactives4030021 · Cited by 1 · see citing works
Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder
Rasheed, S., Arif, R., Raza, A. A., & Samadi, A. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000004349 · Cited by 1 · see citing works
Unequal Healing: Gender, Psychedelics, and the Burden of Care
Viña, S. M. (2026) · Women & Therapy · doi:10.1080/02703149.2026.2615886 · Cited by 1 · see citing works
Psychedelic-assisted psychotherapy: Clarifying the role of the "psychotherapy"
Jerotić, S., Čolović, O., & Marić, N. P. (2026) · Medicinska istrazivanja · doi:10.5937/medi0-62051 · Cited by 1 · see citing works
Koning, E., Gamberg, S., & Keshen, A. R. (2026) · Behavioral Sciences · doi:10.3390/bs16030376 · Cited by 1 · see citing works
McAnulty, C., Lavoie, P., Cyr, S., Lavín, P., Elkrief, L., Richard‐Devantoy, S., Rizkallah, É., Lespérance, P., Gamin, N., Lembke, A., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-116969 · Cited by 1 · see citing works
Psychological support in psychedelic-assisted therapy clinical trials: A systematic review
Brusky, B., M’Baïlara, K., Alla, F., & Barrault, M. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261424204 · Cited by 1 · see citing works
Kazdan, J., Ladha, K. S., & Husain, M. I. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70238 · Cited by 1 · see citing works
Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations
Marazziti, D., Gambini, M., Gurrieri, R., Russomanno, G., Sità, G., Pescini, E., DIGIUSEPPE, F. R., & Mucci, F. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2654682 · Cited by 1 · see citing works
Wallace, L. M., Bujor, A., Sudre, G. P., Kennedy, M., Bahnareanu, D.-E., & Mittal, K. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261430518 · Cited by 1 · see citing works
Psychedelic Art Therapy: The Intersection of Psychedelics, Creativity, and Art Therapy
Wilkinson, R. A., & Gursky, A. B. (2026) · Art Therapy · doi:10.1080/07421656.2026.2641876 · Cited by 1 · see citing works
Mitchell, J., Neitzke‐Spruill, L., Mathai, D. S., Robinson, J. O., Kazan, Z., Averill, L. A., & McGuire, A. L. (2026) · Translational Behavioral Medicine · doi:10.1093/tbm/ibag027 · Cited by 1 · see citing works
Hood, A., & Elkins, G. R. (2026) · Journal of Psychedelic Studies · doi:10.1556/2054.2026.00507 · Cited by 1 · see citing works
Lau, A. A., Arunogiri, S., Raner‐Galutera, B., Lichtwark, S., & Catchlove, S. J. (2026) · Brain and Behavior · doi:10.1002/brb3.71521 · Cited by 1 · see citing works
Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review
da Cruz, L. V. M., Beserra, F. R., FREIND, J. M. K., Rodrigues, S. E., & Mograbi, D. C. (2026) · Journal of Clinical Psychology · doi:10.1002/jclp.70167 · Cited by 1 · see citing works
Patient-centred education for ketamine and esketamine therapies in mood disorders
Kachlik, Z., Cubała, W. J., & Walaszek, M. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261456405 · Cited by 1 · see citing works
Erdmann, L., Breitenstein, B., Badanova, M., Telschow, L., Havenith, M. N., & Dziobek, I. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1777341 · Cited by 1 · see citing works
- Authors
- Cavarra, M., Falzone, A., Ramaekers, J. G., Kuypers, K. P. C., & Mento, C.
- Affiliations
- University of Messina (IT)
- Maastricht University (NL)
- Corresponding author
- Cavarra, Mauro
- Venue
- Frontiers in Psychology
- Publisher
- Frontiers Media SA
- Published
- 2022-06-10
- Volume
- 13
- Pages
- 887255-887255
- ISSN
- 1664-1078 (ISSN-L)
- PMC
- PMC9226617
- OpenAlex
- W4281891940
- Cited by
- 171
- References
- 121
- Citations by year
- 2026: 64 · 2025: 46 · 2024: 47 · 2023: 14
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Keywords
- psychedelic-assisted psychotherapy, psychedelics, set and setting, therapeutic stance, directiveness, patient information, clinical outcomes, relapse, treatment response, therapeutic context
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review